Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Ajovy
Pharma
Teva, on cusp of $4.25B opioid settlement, eyes generics growth
With its opioid litigation poised to enter the rearview, Teva Pharmaceutical is doubling down on generics, biosimilars and specialty meds like Ajovy.
Fraiser Kansteiner
Jul 27, 2022 11:22am
Lilly finds stigma is one of the top problems for migraine
Jun 22, 2022 7:50am
Teva CEO Schultz's pay falls 7% to $14.7M amid sales slump
Mar 17, 2022 7:38pm
Biohaven looks to expand migraine drug Nurtec to rhinosinusitis
Feb 22, 2022 11:16am
Teva's CEO Schultz sizes up potential opioid settlement sum
Feb 10, 2022 8:39am
Teva's Austedo carries blockbuster expectations into 2022
Feb 9, 2022 9:49am
